Programme details

Important information

Please be aware that all times displayed on the website are set to local Paris time (CEST).

This program is subject to change without notice to attendees. The definitive version will be available soon.

Friday, June 10 2022 Saturday, June 11 2022
TV studio 1 / First series: general sessions TV studio 2 / Second series: focused topics
08:00
 - 
08:05

Introduction

Christophe BAUDOUIN.

Welcome from the President

Christophe BAUDOUIN
08:35
 - 
09:00

Keynote Lecture - Light for Health

Kazuo TSUBOTA.

Keynote lecture 1

Kazuo TSUBOTA
09:00
 - 
10:00

New concepts in DED

Christophe BAUDOUIN.

Inflammation or parainflammation?

Stefano BARABINO

Corneal nerves and neuropathic pain

Jesus MERAYO

Friction, osmolarity and inflammation in DED

Gysbert B. VAN SETTEN

Microbiome

Marc LABETOULLE

Discussion

10:15
 - 
11:30

Dry eye: why it becomes a chronic disease?

Stefano BARABINO, Christophe BAUDOUIN.

Autophagia and dry eye

Marc LABETOULLE

The vicious spiral biochemical and anatomic interactions

Christophe BAUDOUIN

Controlling the inflammatory response

Pasquale ARAGONA

The overuse of artificial tears

Stefano BARABINO

Lid management not just one shot

Jose BENITEZ DEL CASTILLO

Discussion

11:30
 - 
12:00

Rapid fire poster session #1

Jose BENITEZ DEL CASTILLO.

Early molecular events in dry eye disease in asymptomatic abnormal subjects: hypothetic considerations on transition from health to disease

Karima KESSAL

Impact of dry eye on social activities after work

Mirjam VAN TILBORG

Ocular surface microbiome in dry eye syndrome (DED): the need to standardize a protocol

Suzanne CLOUGHER

A repository of human tear proteoforms and metabolites as treasure cove of easily accessible translational biomarker candidates

Peter RAUS
12:00
 - 
12:45

Symposium THEA: How to improve meibomian gland function in Dry Eye Disease?

Christina GRUPCHEVA, Elisabeth MESSMER.

Is MGD a single disease?

Christophe BAUDOUIN

Clinical tests to characterize evaporative Dry Eye Disease related to MGD

Gerd GEERLING

Effective treatment options to address evaporative Dry Eye

Elisabeth MESSMER

How does eye mask provide Dry Eye relief?

Christina GRUPCHEVA
13:30
 - 
14:15

Symposium SANTEN: Decoding the management of DED: insights from the real-world

Christophe BAUDOUIN.

The role of ocular surface inflammation in the perpetuation of DED

Christophe BAUDOUIN

Optimising anti-inflammatory management of DED in clinical practice

Jose BENITEZ DEL CASTILLO

The PERSPECTIVE study: insights from the real-world setting

Gerd GEERLING

Discussion

14:15
 - 
14:45

Keynote Lecture - Meibomian gland function and dysfunction

David SULLIVAN.

Keynote lecture 2

David SULLIVAN
14:45
 - 
16:15

TFOS session: what is new in MGD?

Gerd GEERLING, David SULLIVAN.

The prevalence of meibomian gland dysfunction in adults

Jutta HORVATH-WINTER

The prevalence of meibomian gland dysfunction in children

Preeya GUPTA

The role of intense pulsed light therapy as a treatment of meibomian gland dysfunction

Jennifer CRAIG

Eyelid warming devices for the treatment of meibomian gland dysfunction

William NGO

Microblepharon exfoliation for the treatment of meibomian gland dysfunction

Ajay KUMAR VIJAY

Quantum molecular resonance electrotherapy for the treatment of meibomian gland dysfunction

Giulio FERRARI

Discussion

16:30
 - 
17:30

Joint session with Eucornea: Iatrogenic Dry eye

Béatrice COCHENER, Elisabeth MESSMER.

Cosmetic lid surgery and OSD

Jutta HORVATH-WINTER

Eye whiteners

Elisabeth MESSMER

Corneal refractive surgery and DED

Béatrice COCHENER

OSD post intra-vitreal injections

Frederic CHIAMBARETTA

Discussion

17:30
 - 
18:00

Rapid fire poster session #2

Christophe BAUDOUIN.

A molecular network-based lipidomic analysis applied to ocular surface specimens

Romain MAGNY

Visual complaints during the covid-19 pandemic in Spain and Portugal

José SALGADO-BORGES

Changes in gene expression in tears of patients with dry eye disease and meibomian gland dysfunction treated with intensive pulsed light

Carlos VERGÈS

Investigation of the influence of melanocortins on lipid production of meibomian glands using a cell line and a new 3d ex vivo slice culture

Ingrid ZAHN
18:00
 - 
18:45

Symposium Visufarma: Latest advancements in the correct diagnosis and treatment of aqueous and evaporative dry eye: The next generation of eyedrops is born

Sai KOLLI.

Symposium Visufarma: Latest advancements in the correct diagnosis and treatment of aqueous and evaporative dry eye: The next generation of eyedrops is born

10:15
 - 
11:30

The DED patient journey

Francisco FIGUEIREDO.

The Enduring Experience in Dry Eye Diagnosis: A Non-Interventional Study Comparing the Experiences of Patients Living with and without Sjögren’s Syndrome

Francisco FIGUEIREDO

Depression and character traits in Dry Eye Disease

Tina KAISER

Patients’ perspectives on Dry Eye Disease

Stefano BARABINO

Discussion

14:45
 - 
16:15

New technologies for DED diagnosis

Jose BENITEZ DEL CASTILLO.

MMP9 immunoassay

Elisabeth MESSMER

"Swish army knives"

Antonio MATEO

Confocal microscopy

Antoine LABBÉ

Fluorescein breakup patterns for tear film oriented diagnosis for dry eye disease

Norihiko YOKOI

Tear volume assessment techniques

Murat DOGRU

Discussion

16:30
 - 
17:30

Severe inflammatory conditions causing ocular surface disease

Gerd GEERLING, Andrea LEONARDI.

Keynote lecture: GvHD

Philip STEVEN

Pemphigoid

Gerd GEERLING

Severe allergic conditions

Andrea LEONARDI

Thyroid eye disease

Kostas BOBORIDIS

Discussion

TV studio 1 / First series: general sessions TV studio 2 / Second series: focused topics
08:30
 - 
09:00

Keynote Lecture - Linking systemic with ocular surface immunity

Michael E. STERN.

Keynote lecture 3

Michael E. STERN
09:00
 - 
10:00

Management of severe DED patients

Jesus MERAYO.

Trophic maintenance of the ocular surface

Jose BENITEZ DEL CASTILLO

Focus the problem of severe dry eye

Jesus MERAYO

Regeneration of the ocular surface with plasma enriched in growth factors

Jesus MERAYO

Stem Cell Therapy

Margarita CALONGE

Discussion

10:15
 - 
11:30

When DED becomes surgical

Kostas BOBORIDIS.

Eyelid malposition: indications for surgery

Kostas BOBORIDIS

Surgeries for friction-related ocular surface diseases

Norihiko YOKOI

Conjunctivochalasis, LIPCOF, and floppy eyelid: the role of imaging

Edoardo VILLANI

Don’t blame the blink: understanding dry eye symptoms after blepharoplasty

Daniel EZRA

Salivary gland implant for dry eye

Jaime MARTINEZ

Discussion

11:30
 - 
12:00

Rapid fire poster session #3

Elisabeth MESSMER.

Topical link-TSG6 promotes healing and suppresses inflammation in mouse models of dry eye disease and corneal injury

Anthony J. DAY

Treatment outcomes in real-world clinical practice with ciclosporin a 0.1% cationic emulsion for dry eye and severe keratitis: observed changes in clinical signs and ocular symptom severity from the perspective study

Ines LANZI

Efficacy and safety of a water-free cyclosporine 0.1% formulation for the treatment of dry eye disease: the Essence-2 Trial

Sonja KROSSER

High-frequency QMR electric field in the treatment of dry eye disease

Alfredo RUGGERI
12:00
 - 
12:45

Symposium ALCON: The role of other health conditions in triggering the vicious circle of dry eye

Christophe BAUDOUIN.

The vicious circle of dry eye

Christophe BAUDOUIN

Diabetes and Dry Eye

Antonio DI ZAZZO

Cancer and Dry Eye

Marc LABETOULLE

Mental Health and Dry Eye

Jose BENITEZ DEL CASTILLO
13:30
 - 
14:15

Sympo ALLERGAN: Deciphering options to treat DED

Marc LABETOULLE.

What are eye drops for DED made from?

Marc LABETOULLE

Which eye drops for which patient?

Stefano BARABINO

And when eye drops are not enough?

Jose BENITEZ DEL CASTILLO
14:15
 - 
15:30

Treatment strategies in DED

Stefano BARABINO, Margarita CALONGE.

Keynote lecture: Therapeutic management of the wide spectrum of dry eye disease

Margarita CALONGE

How to start treating a patient with dry eye disease

Stefano BARABINO

Place and interest of natural and complementary treatments

Elisabeth MESSMER

Artificial intelligence in the management of dry eye disease

Anis YAZIDI

Discussion

15:45
 - 
16:45

ITDED3 An European consortium for innovation

Philip STEVEN.

Opening Remarks

Philip STEVEN

Consortium Introduction: structure and overall milestones

Philip STEVEN

Drug Discovery

Amalia ENRÍQUEZ-DE-SALAMANCA

Preclinical Drug Development

Arto URTTI

Development of Clinical Tools

Françoise BRIGNOLE-BAUDOUIN
Annabelle RÉAUX-LE GOAZIO

Training Programme

Maria GONZÁLEZ-GARCIA

Early-Stage Researcher Experience and Achievements

Camilla SCARPELLINI

Advisory Board Perspective

Michael E. STERN

Opening Remarks

Philip STEVEN
16:45
 - 
17:00

Concluding remarks

09:00
 - 
10:00

DED made simple for beginners

Marc LABETOULLE.

DED : How not to miss the simple things?

Marc LABETOULLE

Assessment of DED: make it quick and efficient

Elisabeth MESSMER

My first prescription when facing a DED patient

Stefano BARABINO

It didn’t work, Doctor. What else now?

Jose BENITEZ DEL CASTILLO

Discussion

10:15
 - 
11:30

Neuropathic Pain

Stefano BONINI, Margarita CALONGE.

Neuropathic corneal pain: is it really a new clinical entity?

Stefano BONINI

Phenotypic characterization of patients suffering from post-surgery chronic dry eye and pain

Margarita CALONGE

A new esthesiometer for measuring corneal sensitivity

Jesus MERAYO

The role of neuromediators in cornea sensation

Maria MARKOULLI

Discussion

14:15
 - 
15:30

Contact lens/ECLSO session: Contact Lenses in Ocular Surface Problems

Omur UCAKHAN.

Dry eye and Contact Lenses

Andrena MCELVANNEY

Allergy and Contact Lenses

Omur UCAKHAN

Contact lenses in Post-surgical eyes

Cristina NICULA

Contact lens wear during COVID pandemic

Adriana STANILA

Discussion

15:45
 - 
16:45

Young Ophthalmologists: a sense of innovation

Francesc MARCH DE RIBOT.

Dry eye questionnaire: the ocular surface frailty index

Edoardo VILLANI

Young Ophthalmologists: a sense of innovation

Ax TIMON

Digital solutions for dry eye

Luis Alfonso HERNÁNDEZ PIÑAMORA

Discussion


Our partners